| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RXST | RxSight, Inc. | Thunen Shelley B | Chief Financial Officer | Mar 01, 2024 | Sale | $35.99 | 20,000 | 719,709 | 23,691 | Mar 05, 2024, 04:05 PM | |
| RXST | RxSight, Inc. | Thunen Shelley B | Chief Financial Officer | Feb 05, 2024 | Option Exercise | $23.68 | 25,150 | 595,451 | 22,816 | Feb 07, 2024, 05:18 PM | |
| RXST | RxSight, Inc. | Thunen Shelley B | Chief Financial Officer | Feb 06, 2024 | Option Exercise | $31.21 | 31,750 | 990,905 | 29,566 | Feb 07, 2024, 05:18 PM | |
| RXST | RxSight, Inc. | Thunen Shelley B | Chief Financial Officer | Jan 26, 2024 | Sale | $29.32 | 68,044 | 1,995,358 | 38,563 | Jan 29, 2024, 05:36 PM | |
| RXST | RxSight, Inc. | Thunen Shelley B | Chief Financial Officer | Dec 15, 2023 | Sale | $39.32 | 20,000 | 786,326 | 38,402 | Dec 18, 2023, 07:09 PM | |
| RXST | RxSight, Inc. | Thunen Shelley B | Chief Financial Officer | Dec 15, 2023 | Option Exercise | $27.47 | 40,000 | 1,098,984 | 22,291 | Dec 18, 2023, 07:09 PM | |
| ELGX | ENDOLOGIX INC /DE/ | Thunen Shelley B | Chief Financial Officer | May 22, 2015 | Option Exercise | $16.45 | 954 | 15,693 | 53,995 | May 26, 2015, 02:15 PM | |
| ELGX | ENDOLOGIX INC /DE/ | Thunen Shelley B | Chief Financial Officer | Feb 27, 2015 | Option Exercise | $15.77 | 1,673 | 26,383 | 54,949 | Mar 02, 2015, 04:08 PM | |
| ELGX | ENDOLOGIX INC /DE/ | Thunen Shelley B | Chief Financial Officer | Mar 11, 2014 | Option Exercise | $13.85 | 2,384 | 33,018 | 37,616 | Mar 13, 2014, 03:27 PM |
Menu